| Full Name | Care Doc Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 4500 13th St, Gulfport, Mississippi |
| Authorized Official Name and Position | Nathan D. Boles (CEO) |
| Authorized Official Contact | 2282561831 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Care Doc Llc 2194 Harmanson Vue Biloxi MS 39531-5273 Ph: (228) 236-3872 | Care Doc Llc 4500 13th St Gulfport MS 39501-2515 Ph: (228) 256-1831 |
| NPI Number | 1225505993 |
|---|---|
| Provider Enumeration Date | 10/31/2018 |
| Last Update Date | 12/11/2023 |
| Medicare PECOS PAC ID | 7719223957 |
|---|---|
| Medicare Enrollment ID | O20190109002502 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225505993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | David Northington |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780690750 PECOS PAC ID: 5991693632 Enrollment ID: I20040305000368 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Charles A Stanich |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356424576 PECOS PAC ID: 3577563139 Enrollment ID: I20070104000171 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Nathan D Boles |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1730277757 PECOS PAC ID: 0244295533 Enrollment ID: I20070322000405 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Mousa Maalouf |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1780799981 PECOS PAC ID: 5698841229 Enrollment ID: I20080905000342 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Stephen P Johns |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1881709053 PECOS PAC ID: 8426114877 Enrollment ID: I20090310000178 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Frederick Joseph Pakron |
|---|---|
| Provider Type | Practitioner - Pulmonary Disease |
| Provider Identifiers | NPI Number: 1538196142 PECOS PAC ID: 4981753696 Enrollment ID: I20090528000267 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Yvette Susi Folse |
|---|---|
| Provider Type | Practitioner - Physical Medicine And Rehabilitation |
| Provider Identifiers | NPI Number: 1811929292 PECOS PAC ID: 1850421702 Enrollment ID: I20100619000046 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Amanda Louise Osborne |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1346548096 PECOS PAC ID: 0446435606 Enrollment ID: I20110503000573 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Raymond P Blythe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1700210432 PECOS PAC ID: 3577786706 Enrollment ID: I20140515001570 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Jessica K Mitchell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1912327289 PECOS PAC ID: 5496972473 Enrollment ID: I20140814002547 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Carla Ann Rushing |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023417938 PECOS PAC ID: 8325361504 Enrollment ID: I20141218001914 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Ashley Blappert |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1154728483 PECOS PAC ID: 7517285091 Enrollment ID: I20150413001985 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Erin Kijonka |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1376993394 PECOS PAC ID: 7315235744 Enrollment ID: I20161018000467 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Brittany Stewart Everhart |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891289955 PECOS PAC ID: 6305193152 Enrollment ID: I20180725000380 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Dasha N Cowart |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1528473329 PECOS PAC ID: 7719264324 Enrollment ID: I20181211003421 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
| Provider Name | Patrick Stovall |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1376004549 PECOS PAC ID: 3971934571 Enrollment ID: I20230831000981 |
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
News Archive
Two-thirds of nursing home residents in a new UAB (University of Alabama at Birmingham) study had no record of or reference to an eye examination in their medical charts, although more than half were visually impaired.
PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is launching two technology platforms – Initiator™ and PKS™ - that will provide dramatic improvements in clinical study timelines by accelerating data acquisition and the processing of final client reports in its Phase I clinics. By providing clients with real time data faster, sponsors can make informed decisions about their products earlier in the process.
Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat chronic and acute wounds, today launched Microcyn Skin & Wound HydroGel for both the U.S. professional and over-the-counter markets. The Microcyn HydroGel received FDA 510(k) marketing clearance in May of this year.
Severe forms of malaria such as Plasmodium falciparum may be deadly even after treatment with current parasite-killing drugs.
A council of leading prostate cancer experts is working to protect the lives of American men by providing lifesaving prostate cancer screenings. The Prostate Conditions Education Council – a national organization committed to men's health and a leader in prostate cancer screening – is once again coordinating free or low-cost screenings as part of its national Prostate Cancer Awareness Week to help encourage men to protect their health.
› Verified 9 days ago
Centerwell Senior Primary Care-gulfport Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12057 Highway 49 Ste C, Gulfport, MS 39503 Phone: 228-832-9385 Fax: 877-504-6444 | |
My Brother's Keeper, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1221 Bridge St, Gulfport, MS 39507 Phone: 769-216-2455 | |
Children's International, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 15465 Oak Ln, Gulfport, MS 39503 Phone: 228-831-8800 Fax: 228-831-8020 | |
Coastal Family Health Center Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 15024 Martin Luther King Jr Blvd, Gulfport, MS 39501 Phone: 228-864-0003 Fax: 228-374-0856 | |
Gulf Coast Endocrinology Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4540 W Railroad St, Gulfport, MS 39501 Phone: 228-867-6062 Fax: 228-867-2598 | |
Physicians Clinic At Mhg Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12261 Highway 49, Suite 11 F, Gulfport, MS 39503 Phone: 228-867-5185 Fax: 228-867-5186 | |
Physicians Clinic At Mhg Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4500 13th St, Gulfport, MS 39501 Phone: 228-867-5201 Fax: 228-867-3152 |